Volume 32, Number 8—August 2026
Research
Virulence of Burkholderia pseudomallei Strains from Western Hemisphere and Africa in Mice
Table 4
Bacterial count in survivors of select dose-groups of C57BL/6 mouse models in a study of Burkholderia pseudomallei virulence
| Strain | Inhaled dose | Organ | No. survivors | No. organs Infected | CFU/g, range |
|---|---|---|---|---|---|
| GHD1A |
1.71 × 101 | Lungs | 7 | 0 | 0 |
| Spleen | 7 | 0 | 0 | ||
| Brain | 7 | 1 | 9.26 × 10° | ||
| 1.68 × 102 | Lungs | 5 | 2 | 3.18 × 103–4.00 × 103 | |
| Spleen | 5 | 0 | 0 | ||
| Brain | 5 | 2 | 8.75 × 102–2.19 × 103 | ||
| 1.88 × 103 |
Lungs | 2 | 1 | 2.94 × 101 | |
| Spleen | 2 | 0 | 0 | ||
| Brain |
2 |
1 |
8.93 × 101 |
||
| BpNY2023b |
1.24 × 101 | Lungs | 8 | 0 | 0 |
| Spleen | 8 | 0 | 0 | ||
| Brain | 8 | 1 | 1.54 × 101 | ||
| 1.02 × 102 |
Lungs | 5 | 1 | 2.26 × 103 | |
| Spleen | 5 | 1 | 1.85 × 105 | ||
| Brain |
5 |
3 |
1.96 × 101–3.93 × 102 |
||
| AZ1999 |
1.29 × 102 | Lungs | 8 | 2 | 2.94 × 101–1.07 × 102 |
| Spleen | 8 | 0 | 0 | ||
| Brain | 8 | 6 | 1.00 × 101–1.75 × 103 | ||
| 8.22 × 102 |
Lungs | 5 | 2 | 3.33 × 101–1.45 × 102 | |
| Spleen | 5 | 0 | 0 | ||
| Brain |
5 |
5 |
1.31 × 102–6.57 × 102 |
||
| VEN1976 |
9.99 × 101 |
Lungs | 6 | 1 | 7.21 × 102 |
| Spleen | 6 | 0 | 0 | ||
| Brain |
6 |
1 |
1.44 × 103 |
||
| PB10007001 |
1.20 × 102 | Lungs | 6 | 1 | 4.09 × 102 |
| Spleen | 6 | 0 | 0 | ||
| Brain | 6 | 1 | 3.73 × 103 | ||
| 4.63 × 102 |
Lungs | 2 | 1 | 2.30 × 102 | |
| Spleen | 2 | 0 | 0 | ||
| Brain |
2 |
2 |
6.78 × 101–6.76 × 102 |
||
| IL2014 |
6.65 × 101 | Lungs | 9 | 1 | 1.07 × 104 |
| Spleen | 9 | 2 | 8.44 × 107–1.08 × 108 | ||
| Brain | 9 | 6 | 7.41 × 101–8.25 × 104 | ||
| 4.19 × 102 |
Lungs | 3 | 1 | 3.75 × 101 | |
| Spleen | 3 | 0 | 0 | ||
| Brain |
3 |
2 |
1.79 × 101–2.19 × 102 |
||
| PR2013a |
6.31 × 101 | Lungs | 8 | 1 | 4.41 × 101 |
| Spleen | 8 | 0 | 0 | ||
| Brain | 8 | 2 | 8.93 × 100–3.23 × 101 | ||
| 4.87 × 102 |
Lungs | 5 | 1 | 4.00 × 101 | |
| Spleen | 5 | 1 | 6.82 × 101 | ||
| Brain |
5 |
4 |
2.42 × 102–2.75 × 103 |
||
| GHC5E |
5.27 × 101 | Lungs | 7 | 1 | 1.85 × 102 |
| Spleen | 7 | 0 | 0 | ||
| Brain | 7 | 2 | 1.53 × 102–3.51 × 102 | ||
| 4.22 × 102 |
Lungs | 1 | 0 | 0 | |
| Spleen | 1 | 0 | 0 | ||
| Brain |
1 |
1 |
1.09 × 102 |
||
| MS2020a |
7.43 × 101 | Lungs | 3 | 0 | 0 |
| Spleen | 6 | 0 | 0 | ||
| Brain | 3 | 0 | 0 | ||
| 3.53 × 103 |
Lungs | 4 | 1 | Detected, unquantifiable because contaminated | |
| Spleen | 4 | 1 | Too numerous to count | ||
| Brain |
4 |
1 |
Detected, unquantifiable because contaminated |
||
| Tx2004 | 2.98 × 102 | Lungs | 7 | 0 | 0 |
| Spleen | 7 | 0 | 0 | ||
| Brain | 7 | 0 | 0 | ||
| 1.21 × 103 | Lungs | 6 | 1 | 5.29 × 107 | |
| Spleen | 6 | 1 | 1.20 × 109 | ||
| Brain | 6 | 1 | 1.25 × 102 |
Page created: June 09, 2026
Page updated: July 28, 2026
Page reviewed: July 28, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.